MovDisordV3, PascalFrancis, Curation, bibRecord, 001040

Use of complementary therapies in patients with Parkinson's disease in singapore

Identifieur interne : 001040 ( PascalFrancis/Curation ); précédent : 001039; suivant : 001041

Use of complementary therapies in patients with Parkinson's disease in singapore

Auteurs : Louis C. S. Tan [Singapour] ; Puay-Ngoh Lau [Singapour] ; Roland Dominic G. Jamora [Singapour] ; Edwin S. Y. Chan [Singapour]

Source :

Movement disorders [ 0885-3185 ] ; 2006.

RBID : Pascal:06-0135501

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Parkinson maladie, Traitement, Homme, Singapour, Médecine parallèle, Acupuncture, Vitamine.
Wicri :
- geographic : Singapour.
- topic : Homme, Vitamine.

English descriptors

KwdEn :
- Acupuncture, Alternative medicine, Human, Nervous system diseases, Parkinson disease, Singapore, Treatment, Vitamin.

Abstract

To determine the frequency and spectrum of complementary therapy (CT) use and its association with sociodemographic or disease-specific characteristics among Asian patients with Parkinson's disease (PD) in Singapore, we interviewed 159 patients using a structured questionnaire. Sixty-one percent (95% CI = 55-67) of participants used at least one type of CT for PD, of which the most common were traditional medicine, acupuncture, and vitamins/health supplements. Among CT users, 40% (95% CI = 32-48) subjectively reported some improvement of their symptoms. However, only 16% informed their physicians of their use of CT. Due to unequal follow-up times, a survival analysis approach was adopted for statistical analysis. The rate of starting CT use was 1.2/100 person months. At 3 years after PD diagnosis, 48% had started using CT. Among a subgroup of participants, those with a baseline Unified Parkinson's Disease Rating Scale motor score of more than 16 were 2.5 times more likely to use CT compared to those with a baseline score of 16 or less (P = 0.031; 95% CI = 1.1-5.8). CT use was not associated with age of onset of PD or other sociodemographic factors. The use of CT is high among Asian PD patients. Patients with more severe motor dysfunction at onset are more likely to use CT.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 21`
A06				`@2 1`
A08	`01`	`1`	`ENG`	`@1 Use of complementary therapies in patients with Parkinson's disease in singapore`
A11	`01`	`1`		`@1 TAN (Louis C. S.)`
A11	`02`	`1`		`@1 LAU (Puay-Ngoh)`
A11	`03`	`1`		`@1 JAMORA (Roland Dominic G.)`
A11	`04`	`1`		`@1 CHAN (Edwin S. Y.)`
A14	`01`			`@1 Department of Neurology, National Neuroscience Institute @3 SGP @Z 1 aut. @Z 3 aut.`
A14	`02`			`@1 Department of Nursing Administration, National Neuroscience Institute @3 SGP @Z 2 aut.`
A14	`03`			`@1 Clinical Trials and Epidemiology Research Unit @3 SGP @Z 4 aut.`
A20				`@1 86-89`
A21				`@1 2006`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000133169150150`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 6 ref.`
A47	`01`	`1`		`@0 06-0135501`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 To determine the frequency and spectrum of complementary therapy (CT) use and its association with sociodemographic or disease-specific characteristics among Asian patients with Parkinson's disease (PD) in Singapore, we interviewed 159 patients using a structured questionnaire. Sixty-one percent (95% CI = 55-67) of participants used at least one type of CT for PD, of which the most common were traditional medicine, acupuncture, and vitamins/health supplements. Among CT users, 40% (95% CI = 32-48) subjectively reported some improvement of their symptoms. However, only 16% informed their physicians of their use of CT. Due to unequal follow-up times, a survival analysis approach was adopted for statistical analysis. The rate of starting CT use was 1.2/100 person months. At 3 years after PD diagnosis, 48% had started using CT. Among a subgroup of participants, those with a baseline Unified Parkinson's Disease Rating Scale motor score of more than 16 were 2.5 times more likely to use CT compared to those with a baseline score of 16 or less (P = 0.031; 95% CI = 1.1-5.8). CT use was not associated with age of onset of PD or other sociodemographic factors. The use of CT is high among Asian PD patients. Patients with more severe motor dysfunction at onset are more likely to use CT.
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C02	`03`	`X`		`@0 002B17F`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Parkinson maladie @5 02`
C03	`02`	`X`	`ENG`	`@0 Parkinson disease @5 02`
C03	`02`	`X`	`SPA`	`@0 Parkinson enfermedad @5 02`
C03	`03`	`X`	`FRE`	`@0 Traitement @5 09`
C03	`03`	`X`	`ENG`	`@0 Treatment @5 09`
C03	`03`	`X`	`SPA`	`@0 Tratamiento @5 09`
C03	`04`	`X`	`FRE`	`@0 Homme @5 10`
C03	`04`	`X`	`ENG`	`@0 Human @5 10`
C03	`04`	`X`	`SPA`	`@0 Hombre @5 10`
C03	`05`	`X`	`FRE`	`@0 Singapour @2 NG @5 11`
C03	`05`	`X`	`ENG`	`@0 Singapore @2 NG @5 11`
C03	`05`	`X`	`SPA`	`@0 Singapur @2 NG @5 11`
C03	`06`	`X`	`FRE`	`@0 Médecine parallèle @5 12`
C03	`06`	`X`	`ENG`	`@0 Alternative medicine @5 12`
C03	`06`	`X`	`SPA`	`@0 Medicina alternativa @5 12`
C03	`07`	`X`	`FRE`	`@0 Acupuncture @5 13`
C03	`07`	`X`	`ENG`	`@0 Acupuncture @5 13`
C03	`07`	`X`	`SPA`	`@0 Acupuntura @5 13`
C03	`08`	`X`	`FRE`	`@0 Vitamine @5 14`
C03	`08`	`X`	`ENG`	`@0 Vitamin @5 14`
C03	`08`	`X`	`SPA`	`@0 Vitamina @5 14`
C07	`01`	`X`	`FRE`	`@0 Asie @2 NG`
C07	`01`	`X`	`ENG`	`@0 Asia @2 NG`
C07	`01`	`X`	`SPA`	`@0 Asia @2 NG`
C07	`02`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`02`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`02`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`03`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`03`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`03`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`04`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`04`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`04`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`05`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`05`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`05`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 086`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001C81

Links to Exploration step

Pascal:06-0135501

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Use of complementary therapies in patients with Parkinson's disease in singapore</title>
<author><name sortKey="Tan, Louis C S" sort="Tan, Louis C S" uniqKey="Tan L" first="Louis C. S." last="Tan">Louis C. S. Tan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Neuroscience Institute</s1>
<s3>SGP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
</affiliation>
</author>
<author><name sortKey="Lau, Puay Ngoh" sort="Lau, Puay Ngoh" uniqKey="Lau P" first="Puay-Ngoh" last="Lau">Puay-Ngoh Lau</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Nursing Administration, National Neuroscience Institute</s1>
<s3>SGP</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
</affiliation>
</author>
<author><name sortKey="Jamora, Roland Dominic G" sort="Jamora, Roland Dominic G" uniqKey="Jamora R" first="Roland Dominic G." last="Jamora">Roland Dominic G. Jamora</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Neuroscience Institute</s1>
<s3>SGP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
</affiliation>
</author>
<author><name sortKey="Chan, Edwin S Y" sort="Chan, Edwin S Y" uniqKey="Chan E" first="Edwin S. Y." last="Chan">Edwin S. Y. Chan</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Trials and Epidemiology Research Unit</s1>
<s3>SGP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0135501</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0135501 INIST</idno>
<idno type="RBID">Pascal:06-0135501</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001C81</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001040</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Use of complementary therapies in patients with Parkinson's disease in singapore</title>
<author><name sortKey="Tan, Louis C S" sort="Tan, Louis C S" uniqKey="Tan L" first="Louis C. S." last="Tan">Louis C. S. Tan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Neuroscience Institute</s1>
<s3>SGP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
</affiliation>
</author>
<author><name sortKey="Lau, Puay Ngoh" sort="Lau, Puay Ngoh" uniqKey="Lau P" first="Puay-Ngoh" last="Lau">Puay-Ngoh Lau</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Nursing Administration, National Neuroscience Institute</s1>
<s3>SGP</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
</affiliation>
</author>
<author><name sortKey="Jamora, Roland Dominic G" sort="Jamora, Roland Dominic G" uniqKey="Jamora R" first="Roland Dominic G." last="Jamora">Roland Dominic G. Jamora</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Neuroscience Institute</s1>
<s3>SGP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
</affiliation>
</author>
<author><name sortKey="Chan, Edwin S Y" sort="Chan, Edwin S Y" uniqKey="Chan E" first="Edwin S. Y." last="Chan">Edwin S. Y. Chan</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Clinical Trials and Epidemiology Research Unit</s1>
<s3>SGP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Singapour</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acupuncture</term>
<term>Alternative medicine</term>
<term>Human</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
<term>Singapore</term>
<term>Treatment</term>
<term>Vitamin</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Parkinson maladie</term>
<term>Traitement</term>
<term>Homme</term>
<term>Singapour</term>
<term>Médecine parallèle</term>
<term>Acupuncture</term>
<term>Vitamine</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Singapour</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Vitamine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To determine the frequency and spectrum of complementary therapy (CT) use and its association with sociodemographic or disease-specific characteristics among Asian patients with Parkinson's disease (PD) in Singapore, we interviewed 159 patients using a structured questionnaire. Sixty-one percent (95% CI = 55-67) of participants used at least one type of CT for PD, of which the most common were traditional medicine, acupuncture, and vitamins/health supplements. Among CT users, 40% (95% CI = 32-48) subjectively reported some improvement of their symptoms. However, only 16% informed their physicians of their use of CT. Due to unequal follow-up times, a survival analysis approach was adopted for statistical analysis. The rate of starting CT use was 1.2/100 person months. At 3 years after PD diagnosis, 48% had started using CT. Among a subgroup of participants, those with a baseline Unified Parkinson's Disease Rating Scale motor score of more than 16 were 2.5 times more likely to use CT compared to those with a baseline score of 16 or less (P = 0.031; 95% CI = 1.1-5.8). CT use was not associated with age of onset of PD or other sociodemographic factors. The use of CT is high among Asian PD patients. Patients with more severe motor dysfunction at onset are more likely to use CT.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>21</s2>
</fA05>
<fA06><s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Use of complementary therapies in patients with Parkinson's disease in singapore</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>TAN (Louis C. S.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LAU (Puay-Ngoh)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>JAMORA (Roland Dominic G.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>CHAN (Edwin S. Y.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, National Neuroscience Institute</s1>
<s3>SGP</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Nursing Administration, National Neuroscience Institute</s1>
<s3>SGP</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Clinical Trials and Epidemiology Research Unit</s1>
<s3>SGP</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>86-89</s1>
</fA20>
<fA21><s1>2006</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000133169150150</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>6 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0135501</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>To determine the frequency and spectrum of complementary therapy (CT) use and its association with sociodemographic or disease-specific characteristics among Asian patients with Parkinson's disease (PD) in Singapore, we interviewed 159 patients using a structured questionnaire. Sixty-one percent (95% CI = 55-67) of participants used at least one type of CT for PD, of which the most common were traditional medicine, acupuncture, and vitamins/health supplements. Among CT users, 40% (95% CI = 32-48) subjectively reported some improvement of their symptoms. However, only 16% informed their physicians of their use of CT. Due to unequal follow-up times, a survival analysis approach was adopted for statistical analysis. The rate of starting CT use was 1.2/100 person months. At 3 years after PD diagnosis, 48% had started using CT. Among a subgroup of participants, those with a baseline Unified Parkinson's Disease Rating Scale motor score of more than 16 were 2.5 times more likely to use CT compared to those with a baseline score of 16 or less (P = 0.031; 95% CI = 1.1-5.8). CT use was not associated with age of onset of PD or other sociodemographic factors. The use of CT is high among Asian PD patients. Patients with more severe motor dysfunction at onset are more likely to use CT.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B17F</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Homme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Human</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Hombre</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Singapour</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Singapore</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Singapur</s0>
<s2>NG</s2>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Médecine parallèle</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Alternative medicine</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Medicina alternativa</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Acupuncture</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Acupuncture</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Acupuntura</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Vitamine</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Vitamin</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Vitamina</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Asie</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Asia</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>086</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001040 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001040 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:06-0135501
   |texte=   Use of complementary therapies in patients with Parkinson's disease in singapore
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Use of complementary therapies in patients with Parkinson's disease in singapore

Use of complementary therapies in patients with Parkinson's disease in singapore

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri